Drug Database
Back to search

Poland· PL-100421968

Fingolimod Teva

A fingolimod product containing fingolimodum, registered in Poland by Teva Pharmaceuticals Polska Sp. z o.o.. The same ATC class is registered in 16 of our 19 countries.

ATC L04AE01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedFingolimod TevaATCL04AE01REGISTER NO.PL-100421968PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about fingolimodumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Fingolimod is registered in 16 of 19 countries.

Countries holding a registration under ATC L04AE01 (fingolimod), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose
Search fingolimod products by name

Fingolimod · ATC L04AE01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of fingolimod costs, country by country.

Normalised to the WHO defined daily dose (0.5 mg), so markets compare like for like.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Fingolimod · price per daily dose (0.5 mg)

USD · FX 28 Sept 2026

  • IT Italy$27.25
  • CH Switzerland$18.53
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Fingolimodum
Manufacturer
Teva Pharmaceuticals Polska Sp. z o.o.
Country
Poland (PL)
ATC code
L04AE01
ATC class
Fingolimod
Defined daily dose
0.5 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909991448028
  • gtin
    05909991461751

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

584 interactions on record for fingolimod.

Graded by severity as the source publishes them — 503 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check fingolimod against other medicinesHow interaction checks work

Fingolimod · interactions on record

584 records

  • 503 severe
  • 77 moderate
  • 4 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under L04AE01

Fingolimod, as other registers publish it.

All fingolimod products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/90ddb8ee-00ee-4fc0-bec5-f7783c56ae9b
GET /v1/drugs/90ddb8ee-00ee-4fc0-bec5-f7783c56ae9b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki twarde",
  "source": "urpl",
  "strength": "0,5 mg",
  "packaging": "05909991448028 ¦ Rpz ¦ 139203\n28 kaps.\n05909991461751 ¦ Rpz ¦ 141365\n7 kaps.",
  "substance": "Fingolimodi hydrochloridum 0.56 mg",
  "common_name": "Fingolimodum",
  "pl_product_id": "100421968",
  "pozwolenie_nr": "26278",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about fingolimod.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console